Publication | Closed Access

Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN)

UrologyOncologyDrug TargetingGenitourinary CancerMedicineNovel Therapeutic CombinationTumor TargetingAnti-cancer AgentCancer TreatmentSimultaneous TargetingPharmacologyTumor MicroenvironmentTumor BiologyBladder Tumor Growth